In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).

Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...

We recently compiled a list of the 12 Stocks Under $5 With Biggest Upside Potential. In this article, we are going to take a ...

EST Maravai Lifesciences (MRVI) jumps 6% to $5.85 after MAI IP acquisition announcementInvest with Confidence: Follow TipRanks' Top Wall ...

SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the target of some unusual options trading on ...

TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

Maravai LifeSciences Holdings, Inc. announced that it expects total revenue for 2024 to align with its previous guidance range of $255 million to $265 million based on preliminary year-end results ...

General Counsel Kurt Oreshack sold 25,000 shares of Maravai LifeSciences stock in a transaction on Friday, January 31st. The stock was sold at an average price of $5.03, for a total transaction of ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...

圣地亚哥 - 市值7.96亿美元的生命科学试剂和服务供应商Maravai LifeSciences, Inc. (NASDAQ: MRVI)宣布收购Molecular Assemblies, Inc.的知识产权和资产。根据 InvestingPro 数据，该公司保持强劲的流动性，流动比率为10.74，尽管面临近期挑战，过去十二个月收入下降34%。此次收购将增强Maravai子公司TriLink ...

CEO of Maravai LifeSciences. “We plan to further evolve and enhance Molecular Assemblies’ workflows to push the limits of oligo length and purity, and to lower costs by vertically integrating ...